Press Release | Tue Dec 11, 2012 11:25pm EST

FibroGen and Astellas Announce Initiation of Phase 3 Trial of FG-4592/ASP1517 for Treatment of Anemia of Chronic Kidney Disease

* Reuters is not responsible for the content in this press release.